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Abstract
Background: Dysmenorrhea is highly prevalent and is the leading cause of absence from school and work among
women of reproductive age. Evidence suggests that dysmenorrhea may also be a risk factor for other chronic pain
conditions. Limited research has examined women’s experience with dysmenorrhea using qualitative data. Research
is warranted to address issues and needs that are important from women’s own perspectives. Therefore, the
purpose of this study was to describe women’s salient thoughts about their experiences of dysmenorrhea.
Methods: We analyzed data collected from an open-ended question within a cross-sectional survey study conducted
in the United States. Using qualitative thematic analysis, free text responses to a question asking women to share their
experience with dysmenorrhea were analyzed.
Results: The sample consisted of 225 women who provided valid responses to the open-ended question. Six themes
were identified: (1) The dysmenorrhea symptom experience varied among women; (2) The dysmenorrhea symptom
experience varied across time, (3) A variety of factors influenced the dysmenorrhea symptom experience, (4)
Dysmenorrhea symptoms could have a negative impact on the women’s daily lives, (5) Dysmenorrhea was not seen as
a legitimate health issue by the women, health care providers, or society, and (6) Treatment for women with
dysmenorrhea varied in acceptability and effectiveness.
Conclusions: The findings of this study have important implications for dysmenorrhea symptom assessment and the
development of personalized interventions to support dysmenorrhea management.
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Background
Dysmenorrhea is characterized by abdominal pain
occurring just before and/or during menstruation [1]. Its
prevalence among women of reproductive age ranges
from 16 to 91% [2]. Dysmenorrhea is classified as
primary if it occurs in the absence of underlying patho-
logical findings or secondary if it is related to other
conditions such as endometriosis, fibroids, or pelvic
inflammatory diseases [1, 3, 4]. Without a pelvic examin-
ation, ultrasound, and/or diagnostic laparoscopy, pri-
mary and secondary dysmenorrhea cannot be fully
differentiated [4], and the two types share similar symp-
tomatic treatment approaches [5].
Dysmenorrhea negatively affects women’s quality of
life [6] and is the leading cause of absence from school
and work among women in the reproductive age [7]. It
is also associated with other pain conditions such as
migraines, fibromyalgia, and irritable bowel syndrome
[8–11]. Women with dysmenorrhea, compared to those
without, have been reported to have enhanced pain
sensitivity, which may increase their susceptibility to de-
velop other chronic pain conditions later in life [6, 12, 13].
Scholars suggest that dysmenorrhea may be a fundamen-
tal contributing factor to other painful conditions that are
more prevalent in women [9, 14].
Quantitative studies on dysmenorrhea have shown that
(1) severe pain is experienced by 2–29% of women with
dysmenorrhea [2], (2) gastrointestinal symptoms are
prevalent among women with menstrual pain [15, 16]
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and (3) women use pharmacological and nonpharmaco-
logical strategies to manage dysmenorrhea [17, 18].
Relevant qualitative studies have focused primarily on
endometriosis [19–21], a source of secondary dysmenor-
rhea. Women often experience significant delays in the
diagnosis of endometriosis from the time of symptom
onset [20]. These studies also suggest that endometriosis-
related pain and infertility can negatively affect women’s
social, work, and sex life [20, 21]. Women in these studies,
however, were often recruited from specialized clinics and
women with dysmenorrhea symptoms without a clinical
diagnosis or who were not in treatment were not included.
The goal of the one qualitative study on primary and
secondary dysmenorrhea was to develop an outcome
measure to support labeling claims in pharmaceutical
trials [22].
Research is warranted to address the needs and issues
that are important to women with dysmenorrhea to
improve their quality of life. The purpose of this study,
therefore, was to describe women’s salient thoughts
about their experiences of dysmenorrhea. Such informa-
tion is foundational for the assessment of dysmenorrhea
and the development of person-centered interventions
to support dysmenorrhea management.
Methods
Data collection
The study reported here was part of a larger, cross-
sectional survey of women with dysmenorrhea that
included both quantitative and qualitative data [23]. The
quantitative portion of the study examined self-
management behaviors and is described elsewhere [23].
Participants of the larger survey were recruited from a
list of survey panel registrants (Qualtrics, Provo, UT)
who were willing to be contacted for surveys [24].
Women were eligible if they were over 18 years old, self-
identified as having experienced dysmenorrhea symp-
toms in the last 6 months, were able to read and write
in English, and were living in the United States.
Following approval from the University of Wisconsin-
Madison Health Sciences Institutional Review Board, the
survey provider used demographic data on file to iden-
tify potentially eligible participants and sent them e-mail
invitations to participate in the study. Women who were
interested in participating were informed that comple-
tion of the survey implied consent to participate. A
screening question followed to determine if they had ex-
perienced dysmenorrhea symptoms in the last 6 months.
Data were collected in January and February 2015. The
survey was completed by 762 women.
The larger survey contained items on demographics, clin-
ical characteristics, and dysmenorrhea self-management be-
haviors, as well as one open-ended question at the end.
The question read “Please write anything else you’d like to
share with us about your dysmenorrhea experience.” We
made the assumption that responses to the open-ended
question reflected what was important to women and rep-
resented their salient thoughts about their dysmenorrhea
experiences. For the purpose of the study reported here,
the responses to the open-ended question were analyzed.
Data analysis
The data were analyzed by three team members who are
nurse scientists with expertise in women’s health and/or
qualitative methods. Thematic analysis, as described by
Braun and Clarke [25], was used to analyze the
responses to the open-ended question. In this analysis,
we used a systematic process to find patterned responses
or themes within a narrative data set [25]. We followed
the 6 stage-analysis provided by Braun and Clarke [25]:
(1)Familiarizing yourself with the data. All open-ended
responses were read repeatedly by the research team
members to obtain a sense of the breadth and depth of
the data. The team members met on several occasions
to discuss their initial impressions of the data.
(2)Generating initial codes: All relevant phrases,
sentences, or paragraphs (text units) that related to
the research question were extracted and given a
code, which is a brief label that captures the essence
of the text unit. The team discussed, refined, and
verified all the codes. The codes were then organized
in a data display table.
(3)Searching for themes. The team divided the codes
into broad overarching themes based on code
similarities. Visual representations were developed to
explore the relationships among codes within each
of the themes.
(4)Reviewing themes. The themes were reviewed and
revised by the team and organized into a coherent
pattern. A coherent pattern includes internal
homogeneity (i.e., the codes link together
meaningfully in each theme) and external
heterogeneity (i.e., there are clear distinctions
between the themes). The team then reexamined the
narrative data set as a whole to ensure that all
relevant data were captured by one of the themes.
(5)Defining and naming themes. Each theme was
identified by a statement that captured a distinct
aspect of the dysmenorrhea experience as described
by women.
(6)Producing the report. The final report that provided
a detailed account of each theme was prepared.
Trustworthiness of findings was established through
peer debriefing. Peer debriefing was used at several
stages in the process as two team members (CC and JC)
conducted the initial analysis and a third team member
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(CD) independently validated their conclusions with a
reexamination of data. In addition, one team member
maintained an audit trail to chronicle all methodological
and analytic decisions and this audit trail was routinely
reviewed by other team members. All data display tables
and visual representations of the evolving findings were
retained for the audit trail.
Results
Sample description
Among 762 survey participants, 311 (40.81%) entered
responses to the open-ended question. Eighty-six did
not directly address the question (e.g., “This is an inter-
esting research survey. I hope my opinions mattered”),
and their responses were removed from the analysis.
The final sample consisted of 225 (29.53%) women, and
their responses were included for the thematic analysis.
Women in the final sample had a mean age of
34.7 years (SD = 6.8, Range = 18 to 57). Most were
White/Caucasian (73.8%), and 93.3% grew up in the
United States. About one third had a bachelor’s degree
or above (36.4%), and the majority had insurance
(86.7%). About one-quarter (27.8%) reported having
been diagnosed with conditions related to secondary
dysmenorrhea.
As shown in Table 1, age, race, ethnicity, educational
level, and medication usage rate were similar between
women who provided usable responses and women who
did not. However, compared to women who did not
provide usable responses, women who did were more
likely to (1) have grown up outside of the United States,
(2) report more severe dysmenorrhea symptoms, and (3)
report being diagnosed with a condition related to
secondary dysmenorrhea.
Themes reflecting women’s salient thoughts on
dysmenorrhea
Six themes related to women’s salient thoughts about
dysmenorrhea experiences were identified. Each theme
is described below.
Table 1 Demographics comparison between participants with usable responses to the open-ended question and participants without
usable responses
Participants with usable
responses (N = 225)
Participants without usable
responses (N = 537)
United States Census
Data (%) [36]
Mean (SD) Mean (SD) p*
Age, years 34.8 (6.7) 33.8 (6.4) 0.09
Dysmenorrhea symptom severity
(0 “not severe at all” -10
“extremely severe”)
6.7 (2.2) 6.0 (2.1) < 0.01
n (%) n (%) p**
Hispanic Ethnicity 26 (11.6) 52 (9.7) 0.44 17.6
Race
Asian/Pacific Islander 12 (5.3) 33 (6.2) 0.66 5.6
Black/African American 29 (12.9) 79 (14.7) 0.51 13.3
White/Caucasian 166 (73.8) 410 (76.4) 0.45 77.1
Native American 7 (3.1) 8 (1.5) 0.16 1.2
Bachelor’s degree or above 82 (36.4) 215 (40.0) 0.35 29.3
Had diagnosed with conditions
related to secondary dysmenorrhea
49 (27.8) 88 (16.4) 0.08
Uterine Fibroids 22 (9.8) 37 (6.9) 0.17
Endometriosis 12 (5.3) 31 (5.8) 0.81
Pelvic Inflammatory Disease 11 (4.9) 15 (2.5) 0.14
Others 8 (3.6) 19 (3.6) 0.99
Insured 195 (86.7) 457 (85.1) 0.65
Grew up in the United States 210 (93.3) 522 (97.2) 0.01
Diagnosed with a condition related
to secondary dysmenorrhea
50 (22.2) 87 (16.2) .05
Used Medications for Dysmenorrhea
in the Last 6 Months
172 (76.4) 385 (71.7) 0.18
*Based on independent samples t-test comparison between participants with and without usable responses
** Based on χ 2 tests between participants with and without usable responses
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Theme 1: The dysmenorrhea symptom experience varied
among the women
The women described their symptoms in a wide variety
of ways. Some women specified the location of their
pain; most had abdominal pain, but some also experi-
enced pain in the lower back, legs, vagina, and head. A
few had “pain all over.” Women commonly had gastro-
intestinal symptoms including “menstrual nausea,”
vomiting, gas, bloating, diarrhea, and “bubbling gut.”
These symptoms could occur with or independently of
menstrual pain. One participant, for example, wrote,
“For me, it’s really the strong increase in bowel move-
ments that I notice.”
The women indicated that the symptom severity
ranged from “never bad” to “unbearable,” “horrible,” and
“excruciating.” One woman wrote that her menstrual
pain was “worse than vaginal delivery.” A few women
described their symptoms as “annoying,” “gross,” “haunt-
ing,” and “worrisome,” causing some to “dread” their
menstrual periods. Several wished for menopause or a
hysterectomy to end the pain. A few women had such
severe pain they had visited emergency rooms to obtain
analgesics.
The women often compared their symptoms to those
of their family members and friends. One woman stated,
“My friends and I all compare period stories.” Several
women stressed that each woman’s experience was
unique. One stated, “All I know is that none of us
experience exactly the same thing nor [are] our pain
levels the same. Treating all of us the same doesn’t work
because we aren’t the same.”
Theme 2: The dysmenorrhea symptom experience varied
across time
The women described a number of ways in which dys-
menorrhea symptoms unfolded over time. They indi-
cated that the type and severity of symptoms often
changed from day to day during the menstrual cycle.
One woman wrote, “I get pain and cramps a week before
my period… low back pain, cramps, stomach cramping,
diarrhea, etc., the first day, nausea and migraines the
second day.”
Others described changes from one menstrual cycle to
another. They had symptoms in some months, but not
other months, and symptoms could vary in type or
severity from cycle to cycle. One woman wrote that her
cycles were “never the same, in terms of how much pain
comes and what symptoms occur.” Another wrote,
“Mine [my pain] is every other period, one month it’s
super light and not really painful, then the next month
it’s horrible! For years it’s been like this.”
Some women indicated that their symptoms had chan-
ged over the years. These women described increasing,
decreasing, fluctuating, or stable symptoms in relation
to pregnancy, childbearing, aging, and/or menopause.
Some had heard from other women that dysmenorrhea
symptoms would decrease with aging and childbearing
but were disappointed when this did not occur. One
wrote, “I keep hoping that as I get older it would get
better, but it has gone just the opposite,” and another
wrote, “I was told back then in Africa that the dysmen-
orrhea would stop completely once I have kids. An old
wives’ tale I guess, because this is definitely not true in
my case.”
Theme 3: A variety of factors influenced the dysmenorrhea
symptom experience
The women identified several factors that contributed to
or exacerbated dysmenorrhea symptoms. They indicated
that certain characteristics of the menstrual cycle,
including “heavy periods” and menstrual irregularity,
worsened dysmenorrhea symptoms. One woman wrote,
“My menstrual cycle has never been regular. The longer
I go without having a period (e.g., 2 months or more),
the more intense my symptoms become, and my flow
itself picks up a lot as well.” In some cases, the men-
strual irregularities that aggravated their symptoms
occurred during perimenopause.
Some attributed symptoms to other diagnosed health
conditions such as endometriosis, sex hormone imbal-
ances, or uterine fibroids. Others believed a suspected
but an undiagnosed health condition worsened their
symptoms. One woman wrote, “I believe I have endo-
metriosis, although no one has ever diagnosed me with
it. My symptoms match with it.” Other women indicated
that their dysmenorrhea symptoms were caused or exac-
erbated by genetics or heredity, dietary habits (e.g., “eat-
ing cold food or drinking cold drink”), and the recent
removal of intrauterine devices.
Theme 4: Dysmenorrhea symptoms could have a negative
impact on the women’s daily lives
The women indicated that dysmenorrhea had adversely
affected their daily lives in a number of ways. Some were
unable to sit, walk, or stand when they had dysmenor-
rhea symptoms. Others could not leave home and would
lie in bed or “curl up in a ball.” Some could not attend
school or work, enjoy recreational activities (“skipping
parties”), and attend to family responsibilities (e.g. “deal-
ing with kids”) because of their severe symptoms.
A few women indicated that the severity of their sym-
poms put them at risk for medication overdose. One
woman wrote, “This was not intentional but the cramps
were so bad I just kept taking more meds….” Some
women suggested that they were desperate to get relief
from their pain. One woman wrote, “I used to have burn
marks on my abdomen because the heating pads I used
were too hot, but that was the only thing that helped.”
Chen et al. BMC Women's Health  (2018) 18:47 Page 4 of 8
Theme 5: Dysmenorrhea was not always seen as a
legitimate health issue
Some women did not view dysmenorrhea as a legitimate
health issue. They indicated that they thought of their
symptoms as “part of life,” “part of a menstrual cycle,” or
“going along with being a woman.” Several expressed
surprise that the symptoms they had been experiencing
“actually had a name,” and some were unaware there
were treatments available that might provide relief.
The women also revealed that healthcare providers,
employers, and society did not view dysmenorrhea as a
legitimate problem and often showed little sympathy for
women with dysmenorrhea. Several women had dis-
cussed their symptoms with doctors who did not deem
the symptoms to be severe enough to warrant treatment.
One woman suggested to her doctor that she might have
endometriosis, but he just “brushed it off.” Another
woman wrote that “cramps are hard to deal with, but
male bosses (and even some female ones) aren’t very
sympathetic.” Some women suggested that society in
general had little understanding of the toll dysmenorrhea
symptoms can have on women. One woman wrote:
I think that more women experience these symptoms
than [they] will admit, because we don’t want to be
seen as the weaker sex. The truth is that menstruation
(as well as childbearing) have a significant effect on
our bodies…. but there is not enough empathy or
understanding for the physical price we pay.
Theme 6: Treatments for the women with dysmenorrhea
varied in acceptability and effectiveness
The women had a variety of views on and experiences
with dysmenorrhea treatment. Some with severe symp-
toms for whom pregnancy was not a concern tried hor-
monal contraceptives and found they not only relieved
their pain but also regulated their menstrual cycles.
Others were not willing to use “chemical” means to treat
dysmenorrhea, found hormonal contraceptives to be
ineffective, experienced unfavorable side effects (e.g.,
diarrhea, weight gain, mood swings, prolonged periods,
osteoporosis from long-term Depo-Provera use), or
could not use hormonal contraceptives because of age-
related risks. Some women found over-the-counter pain
medications to be effective, whereas others complained
these medications “just take the edge off.” A few experi-
enced relief from endometrial ablation, which was
described by one woman as a short “god-sent” procedure
with fast recovery time. Others favored “natural treat-
ments” including exercise, healthy eating, eating in
smaller portions, and adequate water intake to help with
dysmenorrhea symptoms. Some identified the need for
more research to develop treatment options that are
effective, affordable, and accessible to all women.
Discussion
This study revealed salient thoughts women have about
their dysmenorrhea experiences in the form of six
descriptive themes. Limited research has examined
women’s experience with dysmenorrhea using qualitative
data. By systematically analyzing qualitative data, we
newly identified needs and issues that are important
from women’s own perspectives. Women’s own perspec-
tives are essential to inform person-centered care for
dysmenorrhea. Our study provided new information
about the complex, dynamic, and heterogeneous nature
of dysmenorrhea. By describing the heterogeneity of the
somatology, topography of women’s symptom patterns,
the ways in which the symptoms affect their daily lives,
their beliefs about contributing factors, and their percep-
tions about treatment, these findings provide an
in-depth understanding of dysmenorrhea as experienced
by a broad-based sample of women.
The findings serve as a call for action to improve
dysmenorrhea assessment. Abdominal pain intensity is
typically the only symptom assessed in dysmenorrhea
[26]. Yet consistent with previous studies [16, 22], we
found that many participants experienced pain at mul-
tiple sites and reported a variety of gastrointestinal
symptoms. Previous studies have reported that increased
prostaglandins and pain sensitization among women
with dysmenorrhea are likely to contribute to pain at
multiple sites and gastrointestinal symptoms [3, 11, 27].
Assessment for dysmenorrhea should therefore include
the evaluation of pain at different locations (e.g., abdo-
men, lower back, legs/upper thighs, vaginal area, and
head) and query about gastrointestinal symptoms (e.g.,
nausea, vomiting, diarrhea, and bloating).
Interference of symptoms with daily life has been rec-
ognized as a core outcome of pain research and clinical
care [28], but it has not been commonly assessed in dys-
menorrhea studies [29]. Our study along with others
focusing on endometriosis [19, 22] demonstrate that
dysmenorrhea symptoms interfere with daily life in a
variety of domains (e.g., physical, occupational, recre-
ational, and relational). Such domains are included in
interference scales in available instruments such as the
Brief Pain Inventory [30] and the Patient-Reported Out-
comes Measurement Information System (PROMIS®)
[31]. Future studies should evaluate the applicability and
psychometric properties of these scales on women with
dysmenorrhea.
Although cross-sectional epidemiological studies have
uncovered population-based correlates of dysmenorrhea
such as age and parity [2, 32, 33], our findings suggest
that dysmenorrhea symptoms may fluctuate over time
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with some women reporting increased rather than
decreased symptoms with childbearing, aging, and
menopause. The sub-pattern of increased dysmenorrhea
symptoms with childbearing, aging, and menopause has
rarely been reported in the literature. Longitudinal stud-
ies that could explicate sub-patterns of symptom trajec-
tories and allow researchers to identify protective and
risk factors for these trajectories and/or the development
of chronic pain later in life are needed.
Our findings call for the development of personalized
interventions that target the full range of dysmenorrhea
symptoms. Clinical guidelines [34] that address the man-
agement of menstrual pain and related gastrointestinal
symptoms, and effective pharmacological and nonphar-
macological treatments for dysmenorrhea-related gastro-
intestinal symptoms are needed. Given the complex
nature of dysmenorrhea, multimodal approaches that
combine pharmacological and complementary approaches
may be additively or synergistically beneficial for some
women. A personalized decision aid could help women
choose from among the array of available treatments. The
well-established Ottawa Decision Support Framework [35]
indicates that treatment decisions should cater for individ-
uals’ needs (e.g., needs for pregnancy/contraception),
preferences (e.g., desire for natural treatment and desire
for menstruation), expectations, goals, previous treatment
responses, and treatment risks. Decision aids could improve
dysmenorrhea treatment by validating women’s concerns,
clarifying their needs and preferences, and prompting
shared decision-making with the healthcare provider.
More mechanistic research is needed to understand
individual variations in symptom experiences, symptom
trajectories, and treatment responsiveness. Despite
advances in explicating the role of prostaglandins in the
etiology of dysmenorrhea, it is unclear why some women
with severe dysmenorrhea symptoms have normal pros-
taglandin levels and laparoscopic findings [3]. Uncover-
ing mechanisms underlying this heterogeneity can
generate new insights for developing mechanism-specific
therapies and tailoring therapies for distinct groups.
The findings of this study have implications for clinical
practice. First, healthcare providers should not trivialize
dysmenorrhea. Although not life threatening, dysmenor-
rhea can significantly interfere with the daily lives of
some women. Healthcare providers’ indifference toward
dysmenorrhea can lead to frustration, delayed diagnosis,
and inadequate or ineffective treatment [19]. A vital step
toward effective dysmenorrhea management is to valid-
ate women’s experience. For example, when a woman
reports dysmenorrhea symptoms, a provider might
respond by saying “Menstrual pain is very common, but
it can be distressing and might interfere with your well--
being. I am here to do my best to relieve your symp-
toms.” Second, differences between women should be
given full consideration. Clinical assessment should in-
clude questions about dysmenorrhea severity and
progression, concurrent problems (e.g., heavy menstru-
ation), treatment preferences (including desire for
menstruation, needs for pregnancy/ contraception,
concerns about medications, and attitudes toward non-
medications), treatment contraindications, and history of
treatment responsiveness thus allowing treatment tailor-
ing. For example, in women with severe dysmenorrhea
concurrent with heavy menstruation, the levonorgestrel-
releasing intrauterine device or continuous use of oral
contraceptives may suit their needs [34] especially when
they are open to the absence of menstruation. For
women who do not desire contraception or who prefer
non-pharmaceutical approaches, high-intensity transcu-
taneous electrical nerve stimulation and/or heat may be
reasonable options [5, 34].
These findings should be considered in light of some
study limitations. First, given that the responses were
anonymous and written in response to an open-ended
survey question, we were unable to ask clarifying ques-
tions or to validate our conclusions with participants.
Second, there was potential recall bias in women’s
description of their symptoms. Longitudinal research
using standardized symptom measures could explicate
symptom patterns across time. Third, there was poten-
tial coverage and self-selection bias related to using the
Internet survey. Fourth, our broad-based community
sample served both as strength and limitation. While the
sample allowed us to describe a range of experiences, it
did not allow us to make claims about any specific sub--
groups of women with dysmenorrhea, such as those who
have endometriosis or fibroids. A purposive sample that
systematically includes subgroups of women would allow
such a comparison.
Conclusions
In conclusion, this study provides new information on
the complex, dynamic, and heterogeneous nature of dys-
menorrhea. The findings reported here have implications
for dysmenorrhea symptom assessment, development of
personalized interventions, and future mechanistic stud-
ies. This study underscores the importance of dysmenor-
rhea in women’s health and highlights the need for
additional research and attention to this problem in
clinical practice.
Abbreviation
PROMIS: The Patient-Reported Outcomes Measurement Information System
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